Dirk R J Kuypers, Yves F C Vanrenterghem. Show Affiliations »
Abstract
Mesh: See more » AlemtuzumabAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/therapeutic useGraft Rejection/prevention & controlGraft SurvivalHumansImmunosuppression/methodsKidney Failure, Chronic/surgeryKidney Transplantation/adverse effectsKidney Transplantation/methodsRisk AssessmentSensitivity and SpecificityTransplantation Immunology/drug effectsTransplantation Immunology/physiology
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAlemtuzumabefalizumab
Year: 2004 PMID: 14736949 DOI: 10.1093/ndt/gfg555
Source DB: PubMed Journal: Nephrol Dial Transplant ISSN: 0931-0509 Impact factor: 5.992